Ticker LaunchRegulation A · Tier 2
Aeris Biotechnologies, Inc.
Aeris Biotechnologies, Inc. filed a Tier 2 Regulation A offering statement (Form 1-A) on Apr 25, 2022 for up to $15M at $1.00 per security. The SEC qualified the offering on Jul 26, 2022. Underwriter or broker: D, a and l.
- Status
- Qualified
- Tier
- Tier 2
- Offering size
- $15M
- Offer price
- $1.00
- Security type
- Equity (common or preferred stock)
- Filed
- Apr 25, 2022
- Qualified
- Jul 26, 2022
- Industry
- Pharmaceutical Preparations
- State
- TX
- Underwriter / broker
- D, a, l, m, o, r, e, G, u, p, ,, L and C
More on this offering for subscribers
- Revenue, net income and total assets from the offering statement
- Employees
- Market cap at the offer price
- Auditor
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Offering statement (Form 1-A) Apr 25, 2022
- All filings on EDGAR CIK 1907923
Other qualified Biotech & pharma Reg A offerings
- Maverick Lifestyle Inc.Sep 6, 2022 · $25M
- CBD Life Sciences Inc.Aug 26, 2022 · $9.5M
- Puraverde Inc.Aug 11, 2022 · $50M
- Oncolyze, Inc.Aug 4, 2022 · $15.3M
- Kurve Therapeutics, Inc.Aug 3, 2022 · $50M
- BioLIfe Sciences IncJun 30, 2022 · $20M